Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06953921

Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. assess the impact of albumin level on clinical course and outcomes of HE.

Detailed description

sample size calculation will be performed based on anticipated incidence rates of HE and variability in serum albumin levels, aiming for a study population of 100-150 patients to achieve adequate statistical power. \- All patients included in the study will be subjected to : Glasgow Coma Scale (GCS) score. Clinical Assessment: Baseline evaluation of patients to confirm chronic liver disease diagnosis and determine clinical characteristics. History of prior episodes of HE, presence of ascites, variceal bleeding, and other complications of chronic liver disease . Age, gender, etiology of cirrhosis (e.g., viral hepatitis, alcohol), comorbid conditions (e.g., diabetes, hypertension) * Laboratory investigation : Serum albumin level AST ALT Total bilirubin and direct CBC Serum creatinine Proth time and concetntration

Conditions

Timeline

Start date
2025-03-12
Primary completion
2025-09-12
Completion
2025-09-12
First posted
2025-05-01
Last updated
2025-05-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06953921. Inclusion in this directory is not an endorsement.